Carmell Co. (NASDAQ:CTCX – Get Free Report) was the target of a large growth in short interest in June. As of June 15th, there was short interest totalling 39,400 shares, a growth of 11.0% from the May 31st total of 35,500 shares. Approximately 0.3% of the company’s stock are sold short. Based on an average daily volume of 11,100 shares, the days-to-cover ratio is currently 3.5 days.
Carmell Price Performance
Shares of CTCX traded up $0.31 during midday trading on Monday, reaching $1.64. The stock had a trading volume of 33,076 shares, compared to its average volume of 9,080. Carmell has a 1-year low of $1.11 and a 1-year high of $13.31. The company’s fifty day simple moving average is $2.10 and its two-hundred day simple moving average is $2.79.
Carmell (NASDAQ:CTCX – Get Free Report) last announced its quarterly earnings data on Wednesday, May 15th. The company reported ($0.16) earnings per share for the quarter.
Institutional Investors Weigh In On Carmell
About Carmell
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.
See Also
- Five stocks we like better than Carmell
- ESG Stocks, What Investors Should Know
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- How to Invest in Blue Chip Stocks
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.